The Crystal Structure of BRAF in Complex with an Organoruthenium Inhibitor Reveals a Mechanism for Inhibition of an Active Form of BRAF Kinase

Substitution mutations in the BRAF serine/threonine kinase are found in a variety of human cancers. Such mutations occur in approximately 70% of human malignant melanomas, and a single hyperactivating V600E mutation is found in the activation segment of the kinase domain and accounts for more than 9...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Peng Xie, Craig Streu, Jie Qin, Howard Bregman, Nicholas Pagano, Eric Meggers, Ronen Marmorstein
Formato: Artigo
Lenguaje:inglés
Publicado: 2009
Acceso en línea:https://doi.org/10.1021/bi802067u
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!